Generic Diflucan is an antifungal antibiotic. It is used to treat infections caused by fungus, which can invade any part of the body including the mouth, throat, esophagus, lungs, bladder, genital area and the blood.
Generic Grifulvin is used for treating fungal infections of the scalp, body, foot (athlete's foot), nails, thigh (jock itch), or hair follicles (barber's itch).
Generic Sporanox is an antifungal antibiotic. It is used to treat infections caused by fungus, which can invade any part of the body including the lungs, mouth or throat, toenails or fingernails.
Several Conditions Mimic Nail Fungus in Children - Family Practice News Digital Network
Family Practice News Digital NetworkSeveral Conditions Mimic Nail Fungus in ChildrenFamily Practice News Digital NetworkWhat bothers him the most is not the antifungals, but that the patients didn't need them to begin with because the child didn't have a fungal infection, he said at the annual Hawaii Dermatology Seminar, sponsored by Skin Disease Education Foundation .
Several Conditions Mimic Nail Fungus in Children - Skin and Allergy News Digital Network
Skin and Allergy News Digital NetworkSeveral Conditions Mimic Nail Fungus in ChildrenSkin and Allergy News Digital NetworkWhat bothers him the most is not the antifungals, but that the patients didn't need them to begin with because the child didn't have a fungal infection, he said at the annual Hawaii Dermatology Seminar, sponsored by Skin Disease Education Foundation .
As Fungal Infections Expand, so Does Market - Genetic Engineering News
As Fungal Infections Expand, so Does MarketGenetic Engineering NewsTopical antifungals are generally considered as first-line therapy for uncomplicated, superficial, relatively localized dermatomycoses due to their high efficacy and low potential for systemic adverse effects.
World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) - MarketWatch (press release)
World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)MarketWatch (press release)NEW YORK, Feb.
